Prolonged moderate-intensity exercise in the post-absorptive state causes a continuous increase in the NEFA concentration and oxidation with exercise duration [
10,
17,
34,
40]. Moreover, the continuous increase in the NEFA concentration with duration of exercise implies that the rate of NEFA entering the circulation is higher than the uptake rate of the active muscles. Most of the circulatory NEFAs originate from TAG lipolysis in adipose tissue. Direct measurements across abdominal subcutaneous adipose tissue show a substantial increase in NEFA release at low exercise intensities [
41]. Moreover, no or only a modest increase in adipose tissue NEFA release is found with higher exercise intensity [
9,
41]. Therefore, low-intensity exercise provides an adequate stimulus for abdominal adipose tissue NEFA mobilization. The release of NEFA from subcutaneous adipose tissues depends on the relative contribution of three processes: (1) adipose tissue TAG lipolysis; (2) the rate of adipose tissue NEFA re-esterification into TAG; and (3) adipose tissue blood flow. The adipose tissue NEFA uptake is undetectable at rest [
9,
42] and during exercise [
9]; hence, NEFA re-esterification does not play an important role and the increase in adipose tissue NEFA release can be attributed to an increase in TAG lipolysis. However, the exercise-induced subcutaneous adipose tissue blood flow [
9,
41,
43] and likely capillary recruitment [
44,
45] plays a crucial role in the increase in NEFA release during exercise. The difference between the arterial and adipose tissue venous NEFA concentration is very similar at rest and during exercise. Therefore, the 2- to 3-fold increase in adipose tissue blood flow during exercise is responsible for the increase in the circulatory rate of NEFA [
9]. The importance of adipose tissue blood flow for NEFA release is substantiated by observations in patients with type 2 diabetes who exhibit an exercise-stimulated adipose tissue lipolysis but in whom a high fraction of the liberated NEFA caused by TAG lipolysis could not be released into the circulation since the exercise-induced increase in adipose tissue blood flow was much smaller than in healthy subjects [
46]. The exercise-induced increase in adipose tissue lipolysis and blood flow has mainly been attributed to the elevated catecholamine concentration with exercise [
47,
48]. Moreover, circulating epinephrine is more important than sympathetic nervous activity for the stimulation of adipose tissue lipolysis during exercise [
49,
50], albeit differences in various adipose tissue depots may exist [
51]. Whereas epinephrine may be primarily responsible for the exercise-induced increase in lipolysis, selective β-adrenergic blockage does not completely prevent the increase in lipolysis [
47,
48,
52], suggesting that other mediators play a role in the stimulation of lipolysis during exercise. Atrial natriuretic peptide is a potential candidate since there is evidence that it stimulates adipose tissue lipolysis and is produced during exercise in an intensity-dependent manner [
53‐
55]. Growth hormone and cortisol increase adipose tissue lipolysis [
56‐
58] and are potentially involved in the regulation of adipose tissue lipolysis during exercise. Growth hormone usually increases with exercise but its effect on lipolysis is not manifested until after 1–2 h of exercise [
59] and thus is likely to become more important during prolonged exercise or be involved in the enhanced lipolysis during recovery from exercise [
59]. Interestingly, 4 weeks of high-dose growth hormone supplementation raised the basal lipolytic rate substantially but did not change the exercise-induced increase in lipolysis during 30 min of exercise at 65 % of VO
2max [
60], suggesting that growth hormone does not play an important role in the exercise-induced increase in adipose tissue lipolysis. Cortisol may increase to some extent with prolonged exercise [
61] but this does not coincide with the rapid increase of adipose tissue TAG lipolysis upon the start of exercise. It has been suggested that infused cortisol and growth hormone stimulate systemic and adipose tissue lipolysis in an additive manner; however, it has to be mentioned that the cortisol levels were substantially higher than seen for any form of exercise [
62]. Interleukin-6 (IL-6) is produced by skeletal muscle during exercise in increasing amounts with increased duration [
63], and when recombinant human IL-6 (rhIL-6) is infused it increases systemic lipolysis [
64]. Thus, IL-6 could be a signal from muscle to adipose tissue to coordinate the NEFA supply from adipose tissue with demand from the exercising muscle. However, concomitant IL-6 infusion and exercise fails to raise fatty acid delivery or oxidation [
65], and at rest rhIL-6 infusion does not increase adipose NEFA release but does increase NEFA release from skeletal muscle [
66]. Therefore, IL-6 is not a regulator for the increased adipose tissue NEFA release during exercise, but may be involved in skeletal muscle TAG utilization during exercise.